Search
for
Sort by
Research 571–600 of 1000+
- Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes
- Gelatin-chondroitin-6-sulfate-hyaluronic acid scaffold seeded with vascular endothelial growth factor 165 modified hair follicle stem cells as a three-dimensional skin substitute
- Association Between Interleukin 18 Polymorphisms and Alopecia Areata in Koreans
- Multilineage-differentiating stress-enduring cells alleviate atopic dermatitis-associated behaviors in mice
- Biomarkers of selenium status in dogs
- Multipotent adult progenitor cells grown under xenobiotic-free conditions support vascularization during wound healing
- PSAT1 regulates hair follicle growth and stem cell behavior in cashmere goats
- The effect of GGC and CAG repeat polymorphisms on the androgen receptor gene in response to finasteride therapy in men with androgenetic alopecia
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials
- Delayed hair cycle in mnd2 mutant mice lacking HtrA2 serine protease activity
- Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/β-catenin pathway
- Exhaustive analysis of scalp hair regression: subjective and objective perception from initial hair loss to severe miniaturisation and drug-induced regrowth
- Cutaneous Two-Stage Chemical Carcinogenesis
- Comparative Study of Some Potential Paracrine Factors Produced by Normal and Androgenetic Alopecia Hair Follicles
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Moringa oleifera Seed Oil Nanoemulsion Using Tween 80 and Polyethylene Glycol 400: Oil Characterization and Formula Optimization
- Timing of expression of the core clock gene <i>Bmal1</i> influences its effects on aging and survival
- The functions of ocu-miR-205 in regulating hair follicle development in Rex rabbits
- The functions of ocu-miR-205 in regulating hair follicle development in Rex rabbits
- Nickel Oxide Nanoparticles via Green Synthesis: Insights into Antimicrobial, Antifungal and Dye Degradation Potentials
- Pharmacologically altered Androgens, Brain Activation and Response Inhibition in a Stop-Signal Task in Male Heavy Drinkers
- The functions of ocu-miR-205 in regulating hair follicle development in Rex rabbits
- HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia
- Evaluation of short-term hair follicle storage conditions for maintenance of RNA integrity
- HISTOPATHOLOGIC FINDINGS OF ALOPECIA AREATA IN VIETNAMESE PATIENTS
- In vitro skin models to study epithelial regeneration from the hair follicle
- Evidence for a functional interaction of WNT10A and EBF1 in male-pattern baldness